Cite
APA Citation
Koch, A., Paggiaro, P., Hamilton, A., Hart, L., Korducki, L., De Salvo, M., & Pizzichini, E. (n.d.). p230 Symptomatic benefit of olodaterol QD delivered via Respimat® vs placebo and formoterol BID in patients with COPD: combined analysis from two 48-week studies. Thorax, 68, A180–A181. http://access.bl.uk/ark:/81055/vdc_100135166365.0x00001d